apifiny-header

About APIFINY®

risk-assesment
APIFINY is a cancer specific blood test that may aid clinicians in the assessment of risk for the presence of prostate cancer.

APIFINY [uh-pif-eh-nee] is the only cancer specific, non-PSA blood test available today. The simple blood test measures specific biological markers known to be associated with an immune system response to prostate cancer. It is well known that early detection improves long-term survival rates, therefore this technology along with current screening and detection methods, including family history, may provide additional insight for clinicians to aid in a clinical decision for determining a patient’s risk of prostate cancer…

Read More

APIFINY Information for PatientsInformation for Patients

APIFINY’s non-PSA blood-test results, along with current screening and detection methods, including family history, may provide additional insight for your physician to help assess risk for the presence of prostate cancer…

Read More

APIFINY Information for PhysiciansInformation for Physicians

Find out more about incorporating APIFINY into your practice’s procedures, and how it can fit within the clinical management process for your patients…

Read More

APIFINY Information for LaboratoriesInformation for Laboratories

Offer physicians and their patients access to emerging, innovative science by adding Armune BioScience tests to your laboratory’s diagnostic technologies…

Read More

Prostate Cancer DetectionWhat is Prostate Cancer and How is it Detected?

Prostate cancer is the most common non-skin cancer in America, affecting 1-in-7 men. In this section, we provide an overview of prostate cancer and the methods currently available to test and assess risk for, diagnose, and treat the disease…

Learn More

APIFINY Scientific OverviewScientific Overview

Cancer in early stages is typically detected by identifying cancer-specific serum antigens. Unfortunately, cancer serum antigens are present at very low levels in early-stage disease. Also, cancer antigens are not present in all patients due to heterogeneity of the disease. Detection of serum autoantibody responses to tumors provides…

Read More

Order APIFINY Prostate Cancer TestOrder APIFINY

Orders for the APIFINY non-PSA blood test must be made by a physician (or authorized representative) using the APIFINY Test Requisition Form available here…

Read More